These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35384023)

  • 1. Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome.
    Huang Q; Xu H; Wang X; Mao J; Yu B; Zhu Y; Zhang R; Sun B; Zhang J; Ji W; Ma W; Nie M; Wu X
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):612-621. PubMed ID: 35384023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms.
    Wu ZY; Li YL; Chang B
    World J Gastroenterol; 2020 Nov; 26(44):6909-6922. PubMed ID: 33311939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One Case of Pituitary Stalk Interruption Syndrome Associated with Liver Cirrhosis.
    He H; Li DM
    Endocr Metab Immune Disord Drug Targets; 2023; 23(9):1229-1234. PubMed ID: 36852803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary stalk interruption syndrome and liver cirrhosis associated with diabetes and an inactivating
    Liu Z; Zhao W; Cao C; Wang Y; Xiao L; Wang X; Jin C; Xiao J
    Front Endocrinol (Lausanne); 2023; 14():1297146. PubMed ID: 38152125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients.
    Yuan XX; Zhu HJ; Pan H; Chen S; Liu ZY; Li Y; Wang LJ; Lu L; Yang HB; Gong FY
    World J Gastroenterol; 2019 Apr; 25(14):1741-1752. PubMed ID: 31011258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency.
    Kang SJ; Kwon A; Jung MK; Chae HW; Kim S; Koh H; Shin HJ; Kim HS
    Endocr Pract; 2021 Nov; 27(11):1149-1155. PubMed ID: 34126247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency.
    Sridhar S; Raja BR; Priyanka R; Natarajan S; Soundararajan S; Natarajan V
    Pituitary; 2023 Oct; 26(5):622-628. PubMed ID: 37695468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Mineral Density in Pituitary Stalk Interruption Syndrome: The Role of Insulin-Like Growth Factor-1 and Testosterone at Different Skeletal Sites.
    Zhu Y; Nie M; Wang X; Huang Q; Yu B; Zhang R; Zhang J; Sun B; Mao J; Wu X
    Endocr Pract; 2022 Nov; 28(11):1118-1124. PubMed ID: 35940470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity.
    Dichtel LE; Corey KE; Haines MS; Chicote ML; Kimball A; Colling C; Simon TG; Long MT; Husseini J; Bredella MA; Miller KK
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3624-e3632. PubMed ID: 35779256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease and adult growth hormone deficiency: An under-recognized association?
    Takahashi Y
    Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101816. PubMed ID: 37643935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between pituitary stalk (PS) visibility and the severity of hormone deficiencies: PS interruption syndrome revisited.
    Wang W; Wang S; Jiang Y; Yan F; Su T; Zhou W; Jiang L; Zhang Y; Ning G
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):369-76. PubMed ID: 25845766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary stalk interruption syndrome in 58 Chinese patients: clinical features and genetic analysis.
    Yang Y; Guo QH; Wang BA; Dou JT; Lv ZH; Ba JM; Lu JM; Pan CY; Mu YM
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):86-92. PubMed ID: 23199197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary stalk interruption syndrome in Chinese people: clinical characteristic analysis of 55 cases.
    Guo Q; Yang Y; Mu Y; Lu J; Pan C; Dou J; Lv Z; Ba J; Wang B; Zou X; Yang L; Ouyang J; Yang G; Wang X; Du J; Gu W; Jin N; Chen K; Zang L; Erickson BJ
    PLoS One; 2013; 8(1):e53579. PubMed ID: 23341953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease.
    Dichtel LE; Cordoba-Chacon J; Kineman RD
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1812-1824. PubMed ID: 35172328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Analysis in Pituitary Stalk Interruption Syndrome.
    Guo Q; Zhao J; Yu S
    Int J Endocrinol; 2024; 2024():2493083. PubMed ID: 38828392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases.
    Yang Y; Qi ZR; Zhang TT; Kang YJ; Wang X
    Neuro Endocrinol Lett; 2018 May; 39(2):99-104. PubMed ID: 30183204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma.
    Hwang YA; Lee HW; Ahn SH; Lee EJ; Ku CR; Kim SU
    Front Endocrinol (Lausanne); 2022; 13():1057769. PubMed ID: 36699040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U-Shaped relationship of insulin-like growth factor I and incidence of nonalcoholic fatty liver in patients with pituitary neuroendocrine tumors: a cohort study.
    Hu Y; Yuan C; Abdulnaimu M; Memetmin J; Jie Z; Tuhuti A; Abudueini H; Guo Y
    Front Endocrinol (Lausanne); 2024; 15():1290007. PubMed ID: 38370349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.